<DOC>
	<DOCNO>NCT00737191</DOCNO>
	<brief_summary>RATIONALE : Opioids lessen pain cause cancer . It yet know whether opioids effective give together without olanzapine treat cancer pain . PURPOSE : This randomized clinical trial study opioids see well work give together without olanzapine treat patient moderate severe cancer pain .</brief_summary>
	<brief_title>Opioids With Without Olanzapine Treating Patients With Moderate Severe Cancer Pain</brief_title>
	<detailed_description>OBJECTIVES : - To assess analgesic effect olanzapine administer combination opioids patient cancer pain . - To assess opiod-sparing effect olanzapine v placebo . - To assess effect olanzapine opioid adverse effect . OUTLINE : Patients undergo opioid titration step 3 opioid maintain le 4/10 level pain ( 0-10 numeric pain rating scale ) establish opioid start dose . When pain rating increase , patient randomize 1 3 treatment arm . - Arm I : Patients receive oral opioid oral placebo daily 4 week . - Arm II : Patients receive oral opioid 2.5 mg oral olanzapine daily 4 week . - Arm III : Patients receive oral opioid 5 mg oral olanzapine daily 4 week . Patients undergo quality life assessment baseline three time weekly questionnaire use scale 0-3 pain assessment periodically Brief Pain Inventory , Edmonton Symptom Assessment Scale , Linear Analogue Scale Assessments , Mini-Mental State Examination .</detailed_description>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Moderate severe cancer pain Pain score ≥ 7/10 ( 010 numeric pain rating scale ) Requires strong opioids ( step 3 ) pain control already stable dos step 3 opioids Opioid induce cognitive dysfunction cognitive impairment , define cognitive disorder otherwise specify accord Diagnostic Statistical Manual Mental Disorders ( DSMIV ) allow No nonmalignant pain If patient malignant nonmalignant pain , eligibility determine predominant site pain PATIENT CHARACTERISTICS : Life expectancy ≥ 3 month Normal renal function Not pregnant nursing Negative pregnancy test Must telephone Able complete patient questionnaires alone assistance No delirium No hepatic dysfunction No nursing home patient No intractable nausea vomit No true allergy intolerance opioids No gastrointestinal pathology influence absorption opioids No drug seek behavior recent substance abuse history No major depression No respiratory compromise No evidence severe uncontrolled systemic disease ( e.g. , unstable uncompensated respiratory , cardiac , hepatic , renal disease ) No evidence significant clinical disorder laboratory find make undesirable patient participate study PRIOR CONCURRENT THERAPY : More 1 month since prior radiotherapy , chemotherapy , radionuclides More 1 month since prior bisphosphonates No prior surgery influence absorption opioids No concurrent therapeutic procedure treatment influence pain No concurrent active radiation antineoplastic therapy No concurrent retroviral therapy No concurrent drug interfere CYP34A , CYP1A2 , CYP2D6 No concurrent drug interfere morphine metabolism No concurrent medication influence disposition morphine methadone No concurrent antiemetic , antianxiety , neuroleptic agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>hematopoietic/lymphoid cancer</keyword>
	<keyword>pain</keyword>
</DOC>